New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareMatrixyl vs PT-141 (Bremelanotide)

Matrixyl vs PT-141 (Bremelanotide)

Side-by-side comparison of key properties, dosing, and research.

Skin & Cosmetic
Matrixyl
Sexual Health & Libido
PT-141 (Bremelanotide)
Summary
Matrixyl is the most widely used collagen-stimulating cosmetic peptide. As a matrikine — a fragment of type I procollagen — it signals skin cells to synthesize new collagen, elastin, and fibronectin, reducing wrinkle depth and improving skin firmness and elasticity.
PT-141 (Bremelanotide) is a cyclic peptide melanocortin receptor agonist that enhances sexual desire and arousal through central nervous system mechanisms. It is FDA-approved as Vyleesi for premenopausal women with hypoactive sexual desire disorder (HSDD).
Half-Life
N/A — topical; sustained signaling effects on fibroblasts persist beyond single application
2–3 hours
Admin Route
Topical
SubQ
Research
Typical Dose
3–8% concentration
0.5–1.75 mg
Frequency
Once or twice daily
As needed (not daily)
Key Benefits
  • Stimulates collagen I, III, and IV synthesis
  • Increases fibronectin and glycosaminoglycan production
  • Reduces wrinkle depth and length by 27–68% (studies)
  • Improves skin firmness and elasticity
  • Reduces dark circles and undereye bags
  • Synergistic with retinol, vitamin C, and growth factors
  • Suitable for all skin types including sensitive
  • Well-studied with published clinical data
  • Enhances sexual desire and libido in both men and women
  • Improves arousal through central nervous system activation
  • Effective for psychological erectile dysfunction
  • Works for female sexual arousal disorder
  • May improve sexual satisfaction and intensity
  • Fast-acting — effects within 45–60 minutes
  • FDA-approved for HSDD in premenopausal women
Side Effects
  • Exceptional safety profile
  • Non-irritating, suitable for sensitive skin
  • No known adverse effects at cosmetic concentrations
  • Nausea (most common — 40% of users in clinical trials)
  • Facial flushing and warmth
  • Transient blood pressure changes (typically increase then normalize)
  • Headache
  • +2 more
Stacks With